metformin has been researched along with Cardiac Conduction Defect in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin (Met) has a protective effect on the heart." | 1.56 | Metformin ameliorates cardiac conduction delay by regulating microRNA-1 in mice. ( Fang, R; Li, C; Li, R; Li, X; Li, Y; Liang, H; Liu, Y; Lv, L; Shabanova, A; Shan, H; Yang, R; Zhang, L; Zheng, N; Zhou, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, L | 1 |
| Zheng, N | 1 |
| Zhang, L | 1 |
| Li, R | 1 |
| Li, Y | 1 |
| Yang, R | 1 |
| Li, C | 1 |
| Fang, R | 1 |
| Shabanova, A | 1 |
| Li, X | 1 |
| Liu, Y | 1 |
| Liang, H | 1 |
| Zhou, Y | 1 |
| Shan, H | 1 |
1 other study available for metformin and Cardiac Conduction Defect
| Article | Year |
|---|---|
Metformin ameliorates cardiac conduction delay by regulating microRNA-1 in mice.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cardiac Conduction System Disease; Connexin 43; | 2020 |